…and cognitive symptoms) allows precise diagnosis of the cause of symptoms (e.g. post-traumatic migraine, vestibular disorders, epilepsy), whether they have a physiological or structural origin, and enables individualised investigation and…
Content Section:
Articles
…to the EQ-5D for use in multiple sclerosis, and the HIT-6 and MSQ questionnaires for migraine [13]. The future It’s crucial that trials of new treatments in neurology and rehabilitation…
Content Section:
Articles
…the Conference: Discover the new treatments available for those with pain diseases, such as migraine, atopic dermatitis and muscle spasms Develop your knowledge of analgesics for the treatment of pain…
Content Section:
Event News
…gave a succinct and practical lecture on vestibular migraine, discussing the clinical presentation, diagnosis, and treatment options for this disorder. She highlighted the importance of a detailed clinical history and…
Content Section:
Conference Reports
…event is open to HCPs from the UK and Ireland with an interest in headache and migraine. *This link will direct you to a promotional webpage. Teva UK Limited is…
Content Section:
Event News
…Trust and Addenbrookes, then reported how he uses hypnosis within an out-patient department treating Non-Epileptic Seizures and migraine. In a busy clinic there is very little time to make a…
Content Section:
Conference Reports
…neuro-ophthalmology and a truly excellent lecturer and teacher. He went through the differentials for monocular vs binocular transient visual loss, discussed vasospasm in migraines and also spent time discussing the…
Content Section:
Conference Reports
…at glacial pace after decades in Europe. On the other hand, slow release preparations of oxcarbazepine and topiramate (for epilepsy only, not migraine) being launched in the USA, hopefully the…
Content Section:
Conference Reports
…antagonists for migraine treatment. Attendees will learn about Grunenthal’s latest screening approach for neuropathic pain and pain models and hear timely case studies from Merck and Afferent Pharmaceuticals along with…
Content Section:
Event News